SEC Form 4 · accession 0001140361-15-020970
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Baffi
Officer — EVP, Technical Operations
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 7:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2015 | F | 1,566 | $122.78 | D | 104,134 | D | |
| Common StockF1 | May 19, 2015 | G | 1,434 | $0.00 | D | 102,700 | D | |
| Common Stock | May 19, 2015 | G | 1,434 | $0.00 | A | 27,670 | I | Shares held by Baffi Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On May 18, 2015 the reporting person gifted 1434 shares of Common Stock to his family trust. The reporting person is the trustee.